Augmented inositol phosphate production in mesenteric arteries from diabetic rats

Worku Abebe, Kathleen M. MacLeod

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The effects of noradrenaline (NA) on contraction and phosphoinositide metabolism were compared in mesenteric arteries from rats with chronic streptozotocin-induced diabetes and from age-matched control rats. Maximum contractile responses of mesenteric arteries from diabetic rats to NA (30 μM) were significantly greater than control in both the presence and absence of extracellular Ca2+. Basal incorporation of [3H]myoinositol into total [3H]inositol phosphates was greater in diabetic than control mesenteric arteries. NA (30 μM) resulted in a time-dependent increase in total [3H]inositol phosphate production, which was also significantly greater in diabetic than in control preparations. The increase in total [3H]inositol phosphates produced by NA in both control and diabetic arterie was blocked by the α1-adrenoceptor antagonists, prazosin. Absolute levels of inositol 1,4,5-trisphosphate (I(1,4,5)P3), measured by protein binding assay, were also increased in response to 30 μM NA in both control and diabetic arteries. Although basal I(1,4,5)P3 levels were not significantly different, NA-induced increases in I(1,4,5)P3 were significantly greater in diabetic than in control arteries at each time-point measured. These data indicate that phosphoinositide metabolism is enhanced in mesenteric arteries from rats with chronic streptozotocin-induced diabetes in response to a maximum concentration of NA. Augmented production of the second messengers I(1,4,5)P3 and presumably, 1,2-diacylgylcerol may contribute to the enhanced maximum contractile responses of the diabetic arteries to NA.

Original languageEnglish (US)
Pages (from-to)29-36
Number of pages8
JournalEuropean Journal of Pharmacology: Molecular Pharmacology
Volume225
Issue number1
DOIs
StatePublished - Jan 14 1992
Externally publishedYes

Fingerprint

Mesenteric Arteries
Inositol Phosphates
Norepinephrine
Experimental Diabetes Mellitus
Arteries
Phosphatidylinositols
Inositol 1,4,5-Trisphosphate
Prazosin
Second Messenger Systems
Inositol
Protein Binding
Adrenergic Receptors

Keywords

  • Contractile responses
  • Diabetes mellitus
  • Inositol 1,4,5-trisphosphate
  • Inositol phosphates
  • Mesenteric arteries
  • Noradrenaline

ASJC Scopus subject areas

  • Pharmacology

Cite this

Augmented inositol phosphate production in mesenteric arteries from diabetic rats. / Abebe, Worku; MacLeod, Kathleen M.

In: European Journal of Pharmacology: Molecular Pharmacology, Vol. 225, No. 1, 14.01.1992, p. 29-36.

Research output: Contribution to journalArticle

@article{c71a84eccee04299b24a9de0fee43e22,
title = "Augmented inositol phosphate production in mesenteric arteries from diabetic rats",
abstract = "The effects of noradrenaline (NA) on contraction and phosphoinositide metabolism were compared in mesenteric arteries from rats with chronic streptozotocin-induced diabetes and from age-matched control rats. Maximum contractile responses of mesenteric arteries from diabetic rats to NA (30 μM) were significantly greater than control in both the presence and absence of extracellular Ca2+. Basal incorporation of [3H]myoinositol into total [3H]inositol phosphates was greater in diabetic than control mesenteric arteries. NA (30 μM) resulted in a time-dependent increase in total [3H]inositol phosphate production, which was also significantly greater in diabetic than in control preparations. The increase in total [3H]inositol phosphates produced by NA in both control and diabetic arterie was blocked by the α1-adrenoceptor antagonists, prazosin. Absolute levels of inositol 1,4,5-trisphosphate (I(1,4,5)P3), measured by protein binding assay, were also increased in response to 30 μM NA in both control and diabetic arteries. Although basal I(1,4,5)P3 levels were not significantly different, NA-induced increases in I(1,4,5)P3 were significantly greater in diabetic than in control arteries at each time-point measured. These data indicate that phosphoinositide metabolism is enhanced in mesenteric arteries from rats with chronic streptozotocin-induced diabetes in response to a maximum concentration of NA. Augmented production of the second messengers I(1,4,5)P3 and presumably, 1,2-diacylgylcerol may contribute to the enhanced maximum contractile responses of the diabetic arteries to NA.",
keywords = "Contractile responses, Diabetes mellitus, Inositol 1,4,5-trisphosphate, Inositol phosphates, Mesenteric arteries, Noradrenaline",
author = "Worku Abebe and MacLeod, {Kathleen M.}",
year = "1992",
month = "1",
day = "14",
doi = "10.1016/0922-4106(92)90035-T",
language = "English (US)",
volume = "225",
pages = "29--36",
journal = "European Journal of Pharmacology - Molecular Pharmacology Section",
issn = "0922-4106",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Augmented inositol phosphate production in mesenteric arteries from diabetic rats

AU - Abebe, Worku

AU - MacLeod, Kathleen M.

PY - 1992/1/14

Y1 - 1992/1/14

N2 - The effects of noradrenaline (NA) on contraction and phosphoinositide metabolism were compared in mesenteric arteries from rats with chronic streptozotocin-induced diabetes and from age-matched control rats. Maximum contractile responses of mesenteric arteries from diabetic rats to NA (30 μM) were significantly greater than control in both the presence and absence of extracellular Ca2+. Basal incorporation of [3H]myoinositol into total [3H]inositol phosphates was greater in diabetic than control mesenteric arteries. NA (30 μM) resulted in a time-dependent increase in total [3H]inositol phosphate production, which was also significantly greater in diabetic than in control preparations. The increase in total [3H]inositol phosphates produced by NA in both control and diabetic arterie was blocked by the α1-adrenoceptor antagonists, prazosin. Absolute levels of inositol 1,4,5-trisphosphate (I(1,4,5)P3), measured by protein binding assay, were also increased in response to 30 μM NA in both control and diabetic arteries. Although basal I(1,4,5)P3 levels were not significantly different, NA-induced increases in I(1,4,5)P3 were significantly greater in diabetic than in control arteries at each time-point measured. These data indicate that phosphoinositide metabolism is enhanced in mesenteric arteries from rats with chronic streptozotocin-induced diabetes in response to a maximum concentration of NA. Augmented production of the second messengers I(1,4,5)P3 and presumably, 1,2-diacylgylcerol may contribute to the enhanced maximum contractile responses of the diabetic arteries to NA.

AB - The effects of noradrenaline (NA) on contraction and phosphoinositide metabolism were compared in mesenteric arteries from rats with chronic streptozotocin-induced diabetes and from age-matched control rats. Maximum contractile responses of mesenteric arteries from diabetic rats to NA (30 μM) were significantly greater than control in both the presence and absence of extracellular Ca2+. Basal incorporation of [3H]myoinositol into total [3H]inositol phosphates was greater in diabetic than control mesenteric arteries. NA (30 μM) resulted in a time-dependent increase in total [3H]inositol phosphate production, which was also significantly greater in diabetic than in control preparations. The increase in total [3H]inositol phosphates produced by NA in both control and diabetic arterie was blocked by the α1-adrenoceptor antagonists, prazosin. Absolute levels of inositol 1,4,5-trisphosphate (I(1,4,5)P3), measured by protein binding assay, were also increased in response to 30 μM NA in both control and diabetic arteries. Although basal I(1,4,5)P3 levels were not significantly different, NA-induced increases in I(1,4,5)P3 were significantly greater in diabetic than in control arteries at each time-point measured. These data indicate that phosphoinositide metabolism is enhanced in mesenteric arteries from rats with chronic streptozotocin-induced diabetes in response to a maximum concentration of NA. Augmented production of the second messengers I(1,4,5)P3 and presumably, 1,2-diacylgylcerol may contribute to the enhanced maximum contractile responses of the diabetic arteries to NA.

KW - Contractile responses

KW - Diabetes mellitus

KW - Inositol 1,4,5-trisphosphate

KW - Inositol phosphates

KW - Mesenteric arteries

KW - Noradrenaline

UR - http://www.scopus.com/inward/record.url?scp=0026504479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026504479&partnerID=8YFLogxK

U2 - 10.1016/0922-4106(92)90035-T

DO - 10.1016/0922-4106(92)90035-T

M3 - Article

VL - 225

SP - 29

EP - 36

JO - European Journal of Pharmacology - Molecular Pharmacology Section

JF - European Journal of Pharmacology - Molecular Pharmacology Section

SN - 0922-4106

IS - 1

ER -